Physician

Ansa Razzaq, MD

According to 2025 Medicare claims, Ansa Razzaq, MD (NPI: 1629574074) practices critical care (intensivists) in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 07601-1997. Razzaq is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Razzaq's data goes back to 2015 and runs through 2024. For example, in 2022, this provider had 11 traditional Medicare patients, billed 25 HCPCS/CPT codes, and received $2,059 in Medicare payments. 2024 Part D data shows 150 prescription claims across 23 beneficiaries totaling $90,474 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,826 to $90,474. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.